Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
15 Leser
Artikel bewerten:
(0)

Strategies in the Global Nucleic Acid Testing Market 2015 - Profiles of Market Players and Start-up Firms Developing Innovative Technologies and Products

DUBLIN, Aug. 13, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/br9czl/2015_strategies) has announced the addition of the "2015 Strategies in the Global Nucleic Acid Testing Market" report to their offering.

This unique seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

Highlights

  • Five- and ten-year test volume and sales forecasts
  • Market shares of leading competitors
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologies and products
  • Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Worldwide Market Overview

  • Laboratories performing DNA sequencing and NAT by country and market segment.
  • Five-year test volume and sales projections by country.

Market Segmentation Analysis

  • Sales and market shares of major suppliers of NAT reagent kits and components.
  • Ten-year test volume and sales forecasts for major applications, including:
  • - Infectious Diseases
  • - Forensic Testing
  • - Cancer
  • - Paternity Testing/HLA Typing
  • - Genetic Diseases
  • - Others
  • - Ten-year test volume and sales projections for over 30 NAT assays.
  • - A comprehensive analysis of the sequencing market,by country and laboratory segment, including:
  • - Industrial
  • - Academic
  • - Government
  • - Commercial
  • - Detailed

For more information visit http://www.researchandmarkets.com/research/br9czl/2015_strategies

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.